Fluvirin

देश: ऑस्ट्रेलिया

भाषा: अंग्रेज़ी

स्रोत: Department of Health (Therapeutic Goods Administration)

सक्रिय संघटक:

Influenza virus haemagglutinin

थमां उपलब्ध:

Novartis Vaccines & Diagnostics Pty Ltd

वर्ग:

Medicine Registered

सूचना पत्रक

FLUVIRIN
®
 CMI 

FLU_CMI_26Nov2010

Page 1 of 5 
CONSUMER MEDICINE INFORMATION 
FLUVIRIN
®
 2011 
INACTIVATED INFLUENZA VACCINE (SURFACE ANTIGEN) 

WHAT IS IN THIS 
LEAFLET 
This leaflet answers some common 
questions about Fluvirin
®
 vaccine.  
It does not contain all the available 
information.  
It does not take the place of talking 
to your doctor or pharmacist.  
All medicines, including vaccines, 
have risks and benefits. Your 
doctor considers the risks of you or 
your child having Fluvirin
®
 vaccine 
and the benefits he/she expect it 
will have.  
IF YOU HAVE ANY CONCERNS ABOUT 
THIS VACCINE, ASK YOUR DOCTOR, 
NURSE OR PHARMACIST.  
KEEP THIS LEAFLET.  
You may need to read it again.  
WHAT FLUVIRIN
®

VACCINE IS USED FOR 
Fluvirin
 ®
 vaccine helps prevent 
influenza, often called the flu. 
Influenza is caused by infection 
with specific influenza viruses. 
New types of influenza virus can 
appear each year. Fluvirin
®
 vaccine 
contains strains of three different 
types of influenza virus. Each year 
the Australian Influenza Vaccine 
Committee and the New Zealand 
Ministry of Health decide which 
three types of virus are most 
suitable.  

Vaccination against influenza 
helps prevent infection with 
influenza and to control the 
spread of the disease.  
The virus in the vaccine is 
inactivated. Therefore the 
vaccine will not give you or your 
child the flu.  
Note: the vaccine will not 
protect you or your child from 
the other influenza viruses that 
Fluvirin
®
 vaccine does not 
contain. It will not protect you 
from other types of influenza 
virus or from infections with 
other agents causing flu-like 
symptoms (such as the common 
cold). 
Fluvirin
®
 vaccine is available 
only with a doctor's prescription. 
This year (2011) the viruses are 


 A/California/7/2009 
(H1N1)�

उत्पाद विशेषताएं

FLU_PI_26Nov2010 

1/5 
FLUVIRIN
®
 2011 

PRODUCT INFORMATION 

NAME OF THE MEDICINE 
FLUVIRIN
®
 [lnactivated Influenza Vaccine (Surface Antigen) Ph. Eur.].
FLUVIRIN
®
 contains purified 
haemagglutinin and neuraminidase surface
antigens prepared from influenza viruses currently recommended 
by the Australian Influenza Vaccine Committee (AIVC) 

DESCRIPTION 
FLUVIRIN
®
 [inactivated influenza vaccine (Surface Antigen) Ph.
Eur.) is a slightly opalescent, sterile solution 
for injection. Each 0.5 mL single dose syringe
contains 15 micrograms of each of the purified haemagglutinin 
and neuraminidase antigens prepared from the influenza
virus strains currently recommended by the AIVC, 
which for the 2011 Winter are: 

A/California/07/2009 (H1N1) 
– like strain (A/California/07/2009, NYMC X-181); 
A/Perth/16/2009 (H3N2) 
– like strain (A/Victoria/210/2009, NYMC X-187); and 
B/Brisbane/60/2008 
– like strain (B/Brisbane/60/2008, NYMC BX-35). 

The strains chosen for vaccine manufacture are endorsed by the
AIVC as being antigenically equivalent to the 
reference virus. 

The vaccine contains the following excipients: water for
injection, sodium phosphate-dibasic, potassium 
phosphate-monobasic and sodium chloride. 

PHARMACOLOGY 
This vaccine is used for active immunisation against influenza
virus, types A and B, principally for the 
vaccination of those groups regarded as being at special risk,
especially the elderly. 

The vaccine stimulates production of antibodies with a
specific capacity against influenza. Any protection is 
only against those strains of the virus from which
the vaccine is prepared or closely related strains.  

Studies with surface antigen influenza vaccine have shown that the
purified haemagglutinin and 
neuraminidase antigens contained in a single dose of FLUVIRIN
®
 [inactivated Influenza Vaccine (Surface 
Antigen) Ph. E